Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 112.34MRevenues
VS
Market
Sector
Industry
History
$ 10.01Close
$ 9.41 - $ 18.35 52-Week Range
Ticker Information
Ticker
SPRYCompany Name
ARS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQARS PHARMACEUTICALS INC - Revenues Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SPRY - Revenues Historical data
| Date | Revenues |
|---|---|
| 6/30/2025 | $ 112.34M |
| 3/31/2025 | $ 97.12M |
| 12/31/2024 | $ 89.15M |
| 9/30/2024 | $ 2.57M |
| 6/30/2024 | $ 500K |
| 3/31/2024 | $ 10K |
| 12/31/2023 | $ 30K |
| 9/30/2023 | $ 1.35M |
| 6/30/2023 | $ 1.35M |
| 3/31/2023 | $ 1.34M |
Key Performance Insights, Last 5 Years
- ARS PHARMACEUTICALS INC's latest trailing twelve months (TTM) Revenues stands at $ 0.
- Over the past 5 years, ARS PHARMACEUTICALS INC's average Revenues has been $ 17.06M.
- The median Revenues for ARS PHARMACEUTICALS INC during this period was $ 265K
- ARS PHARMACEUTICALS INC reached its highest Revenues over the past 5 years at $ 112.34M.
- The lowest Revenues recorded by ARS PHARMACEUTICALS INC in the same timeframe $ 0
ARS PHARMACEUTICALS INC's Revenues vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Revenues Benchmarks
Similar metrics to Revenues:
- Gross Margin - [Calculation] Gross margin, also called gross profit margin, represents the percentage of total revenue that the company retains after subtracting direct costs associated with producing the goods and services sold by the company [CoR]. Calculated by dividing gross profit [GP] by [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
Definition of Revenues
[Income Statement] The sum of revenue generated from all sold goods and rendered services.SPRY - Revenues, Last 5 years
$ 0
Minimum
Dec 31, 2019
$ 112.34M
Maximum
Jun 30, 2025
$ 17.06M
Average
$ 265K
Median
Revenues Benchmark AnalysisMarket
The chart above depicts the distribution of Revenues for companies in the Total Stock Market. The average Revenues of the companies is $ 490.02M with a standard deviation of $ 675.3M.
The following table provides additional summary stats:
Revenues in the Market:
| filtered constituents | 3.23K |
|---|---|
| min | $ -131.22M |
| max | $ 2.74B |
| average | $ 490.02M |
| median | $ 156.29M |
| std | $ 675.3M |